2007 NAICS Definition
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
Cross-References. Establishments primarily engaged in--
- Manufacturing in-vitro diagnostic substances--are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing; and
- Manufacturing pharmaceutical preparations, (except biological and in-vivo diagnostic substances)--are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.
Index entries that bring you to this industry:
- Agar culture media manufacturing
- Aggressins (except in-vitro) manufacturing
- Allergenic extracts (except diagnostic substances) manufacturing
- Allergens manufacturing
- Antigens manufacturing
- Antiserums manufacturing
- Antitoxins manufacturing
- Antivenoms manufacturing
- Bacterial vaccines manufacturing
- Bacterins (i.e., bacterial vaccines) manufacturing
- Blood derivatives manufacturing
- Blood fractions manufacturing
- Cholera serums manufacturing
- Culture media manufacturing
- Gene therapy preparations manufacturing
- Hematology products (except diagnostic substances) manufacturing
- Plasmas manufacturing
- Serums (except diagnostic substances) manufacturing
- Toxoids (e.g., diphtheria, tetanus) manufacturing
- Tuberculin (i.e., tuberculo-protein derived) manufacturing
- Vaccines (i.e., bacterial, virus) manufacturing
- Virus vaccines manufacturing

Email Updates
Facebook
Twitter
Flickr
YouTube